β Cell death and dysfunction during type 1 diabetes development in at-risk individuals

Role of the funding source: Funding from the NIH was used for support of the participating clinical centers and the coordinating center. The funding source did not participate in the collection or the analysis of the data. BACKGROUND. The β cell killing that characterizes type 1 diabetes (T1D) is th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Invest
Autori principali: Herold, Kevan C., Usmani-Brown, Sahar, Ghazi, Tara, Lebastchi, Jasmin, Beam, Craig A., Bellin, Melena D., Ledizet, Michel, Sosenko, Jay M., Krischer, Jeffrey P., Palmer, Jerry P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Clinical Investigation 2015
Soggetti:
Clinical Medicine
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362259/
https://ncbi.nlm.nih.gov/pubmed/25642774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI78142
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi